SteadyMed, a pharmaceutical company whose focus is the development of products to treat orphan diseases with unmet clinical needs, has…
Margarida Azevedo, MSc
Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Azevedo, MSc
In a new study, researchers determined that elevated serum bilirubin levels and a low 6-minute walk distance are predictors of poor prognosis…
Over the last decade, new oral therapy agents in the form of pills used for the management and treatment of…
Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company that focuses on the development and commercialization of drugs for the treatment of rare diseases and…
A new retrospective study of computed tomographies of chronic obstructive pulmonary disease (COPD) patients shows that chest CT has value…
In a new study, researchers aimed to evaluate nerve distribution around the pulmonary artery — the effect of pulmonary artery…
In a new study, researchers investigated if 3-D phase-contrast observations of wall shear stress (WSS) and oscillatory shear index (OSI)…
In a new retrospective study, researchers show that a procedure called “palliative Senning” improves arterial oxygenation and life quality in children…
Complexa Inc., a biopharmaceutical company developing therapies to treat fibrosis and inflammation-related diseases, announced the successful completion of a Phase 1…
Boehringer Ingelheim Pharmaceuticals, Inc. and the Pulmonary Fibrosis Foundation (PFF) have announced a five-year partnership in an effort to…
Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company that develops and commercializes drugs for the treatment of orphan diseases and conditions with…
New Tool Assesses Right Ventricular Dysfunction in PH, Congenital Heart Disease and Cardiomyopathy
Right ventricular (RV) dysfunction is a characteristic of several disorders such as pulmonary hypertension, congenital heart disease and cardiomyopathy, making RV…